These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6985168)

  • 21. [Dental status in patients with kidney transplants and in a chronic intermittent dialysis program].
    Bartáková V; Kapitán L
    Cesk Stomatol; 1981 Mar; 81(2):107-12. PubMed ID: 7013992
    [No Abstract]   [Full Text] [Related]  

  • 22. [Platelet aggregation in patients with chronic renal insufficiency not under dialytic treatment].
    Camici M; Evangelisti L; Balestri PL
    Minerva Nefrol; 1981; 28(4):467-70. PubMed ID: 7339515
    [No Abstract]   [Full Text] [Related]  

  • 23. [Platelet factor 3 (P-F-3) in chronic renal failure. Effect of dialysis].
    Lasierra Cirujeda J; Sánchez Casajus A; Vilades Juan E
    Rev Clin Esp; 1980 Mar; 156(5):321-4. PubMed ID: 7384579
    [No Abstract]   [Full Text] [Related]  

  • 24. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of epoprostenol (PGI2) versus heparin (H) in hemodialysis (HD).
    Dubrow A; Flamenbaum W; Mittman N; Hall J; Zinn J
    Trans Am Soc Artif Intern Organs; 1984; 30():52-4. PubMed ID: 6398552
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma human brain natriuretic peptide in chronic renal failure.
    Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local microviscosity of platelet membranes from patients with chronic renal failure on hemodialysis].
    Rud'ko IA; Chebotarev VN; Kubatiev AA
    Patol Fiziol Eksp Ter; 1994; (1):20-2. PubMed ID: 8183585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombocyte aggregation during adequate periodic hemodialysis].
    Kiriakov Z; Deliĭski M; Kamenov V; Ionova D
    Khirurgiia (Sofiia); 1985; 38(5):8-11. PubMed ID: 4087773
    [No Abstract]   [Full Text] [Related]  

  • 29. [Platelet and platelet-leukocyte aggregates in the blood of patients during hemodialysis].
    Myśliewiec M; Chmielewska J; Soszka J
    Pol Arch Med Wewn; 1985 May; 73(5):298-304. PubMed ID: 3880369
    [No Abstract]   [Full Text] [Related]  

  • 30. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
    Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
    Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of platelet adhesiveness in chronic renal failure.
    Tiwary A; Lal RL
    J Assoc Physicians India; 1984 Apr; 32(4):321-5. PubMed ID: 6746539
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dialysis treatment of chronic renal failure].
    Thieler H
    Zentralbl Chir; 1993; 118(3):118-21. PubMed ID: 8484283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour markers in chronic renal failure and haemodialysis patients.
    Eskiocak S; Dortok H; Alvur M; Cengiz K
    Nephrol Dial Transplant; 1995; 10(7):1256. PubMed ID: 7478140
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tuberculosis in patients on chronic intermittent dialysis treatment].
    Helm EB; Frei U; Fassbinder W
    MMW Munch Med Wochenschr; 1983 Sep; 125(39):851-2. PubMed ID: 6415462
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombocyte and erythrocyte aggregation and serotonin activity in patients with chronic renal failure].
    Alekseev GI; Potapov VV; Potapova IV
    Ter Arkh; 1979; 51(6):55-8. PubMed ID: 473052
    [No Abstract]   [Full Text] [Related]  

  • 36. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of hemodialysis on the level of cytoplasmic Ca2+ in the thrombocytes of patients with chronic kidney failure].
    Rud'ko IA; Kubatiev AA; Tsalenchuk IaP
    Urol Nefrol (Mosk); 1993; (4):37-9. PubMed ID: 8310566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased endothelin-1 content in the platelets of hemodialysed patients.
    Vlachojannis J; Tsakas S; Chinari E; Orphanos V; Zoumbos N; Kurz P
    Clin Nephrol; 1997 Sep; 48(3):185-90. PubMed ID: 9342491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment.
    Bemis J; Rigney J; Sosin A; Deane N
    Trans Am Soc Artif Intern Organs; 1977; 23():48-53. PubMed ID: 910370
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
    Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.